The site will be operated using the same quality standards as its Healthcare Industries Materials biopharmaceutical manufacturing site in Hemlock, Michigan. The South Carolina manufacturing site will add extrusion capacity online over the next two years to serve more strategic customers and expand its Liveo Healthcare customers with additional supply in the medium term.
“The biopharma processing manufacturing investment at Cooper River is a key milestone in our growth strategy; it supports our customers’ expansion and contributes to business continuity,” DuPont Healthcare and Specialty Lubricants Global Business Director Eugenio Toccalino said in a news release. “We’re committed to investing in our healthcare business, and our recent expansions help us offer a highly reliable and sustainable product supply.”
DuPont Liveo Healthcare will also expand its manufacturing footprint regionally to support more customers locally to alleviate supply pressure. The company said it expects to add biopharma silicone tubing capacity in China in the second half of 2022.
“Through a strong, close collaboration between our DuPont team and our contractor partners, construction of the new Cooper River site was completed in 18 months, without a single safety incident,” said Bill Alexander, Cooper River site and unit leader for the DuPont Liveo and Molykote plants. “The site has enabled the creation of 25 positions at start-up, with an additional 25 positions expected to be created as we ramp up operations over the next two years.”